Overview
HSCS market data
Price History
HSCS price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$9.34 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.77 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.63 – $4.30 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $8 · P/B 18.47 · P/S 922.21.
Company news
Heart Test Laboratories Q4 EPS $(0.87) Misses $(0.73) EstimateBenzinga · Jul 23, 2026, 9:55 PM
Fortitude Mining, HeartSciences Strike Merger Deal; Combined Entity Anticipated To Trade On Nasdaq Under TUDE TickerBenzinga · Jun 23, 2026, 11:40 AM
HeartSciences Receives European Patent For Using Machine-Learning Models And Computation Methods To Calculate Echocardiogram Parameters Using ECG DataBenzinga · Jun 11, 2026, 12:35 PM
HeartSciences Announces Commercial Release Of MyoVista Insights Version 1.3, Platform Update Introducing MyoVista Insights AI-ECG Algorithm MarketplaceBenzinga · Jun 2, 2026, 12:43 PM
HeartSciences Enters Commercial Agreement With North Shore Health Community Hospital To Deploy Its MyoVista Insights PlatformBenzinga · May 19, 2026, 12:40 PM